In elderly breast cancer patients with moderate- to high-risk early-stage disease for whom standard chemotherapy is too toxic, the chemotherapy capecitabine, which causes fewer side effects than the standard chemotherapy agents, did not improve outcomes when tested as monotherapy.
Related Videos In Geriatric Oncology
Nicolaus Kröger, ASH 2018 – Treatment of Myelodysplastic Syndrome in Elderly Patients
Professor Nicolaus Kröger spoke to us at ASH 2018 about the major unmet needs in the treatment of myelodysplastic syndrome in elderly patients, and his phase III study comparing 5-azacytidine induction followed by allogeneic stem cell transplantation versus continuous 5-azacytidine according to donor availability in elderly patients with myelodysplastic syndrome. Questions: 1. What are the […]
Cancer screening complications in the elderly
“Population-based screening is causing more harm than good,” Dr Kataja (Kuopio University Hospital, Kuopio, Finland) says to ecancertv at SIOG 2014. He discusses the complications of cancer screening in the elderly, particularly the risks and benefits of prostate and breast cancer screening in geriatric patients.
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!